Literature DB >> 22167485

Depot formation of doxycycline impairs Tet-regulated gene expression in vivo.

Kathleen Anders1, Christian Buschow, Jehad Charo, Thomas Blankenstein.   

Abstract

The tetracycline (Tet) system is widely used for regulation of gene expression in vitro and in vivo. We constructed C57BL/6 transgenic mice (rtTA-CM2) with strong and ubiquitous reverse transactivator (rtTA2(S)-M2) gene expression. rtTA-CM2 mice were crossed to Tet-responsive reporter mice (LC-1) conditionally expressing the firefly luciferase (FLuc) gene under control of a Tet-responsive element, which allowed sensitive quantification of the transactivator activity by bioluminescent imaging. Following doxycycline (dox) application, up to 10(5)-fold increase in BL signal was measured. rtTA activity was inducible in most analyzed organs. After dox withdrawal the BL signal decreased significantly but did not disappear completely, most likely due to a dox depot formation in vivo. The residual dox was sufficient to partly down-regulate a Tet-off controlled oncogene in a tumor transplantation experiment, resulting in reduced tumor growth. rtTA-CM2 mice may be a useful tool to analyze the function of genes in various organs but also reveal that down-regulation of gene expression is not complete.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167485     DOI: 10.1007/s11248-011-9580-0

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  18 in total

1.  Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5.

Authors:  J Miyazaki; S Takaki; K Araki; F Tashiro; A Tominaga; K Takatsu; K Yamamura
Journal:  Gene       Date:  1989-07-15       Impact factor: 3.688

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

Authors:  Konrad Hochedlinger; Yasuhiro Yamada; Caroline Beard; Rudolf Jaenisch
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Persistent effects induced by IL-13 in the lung.

Authors:  Patricia C Fulkerson; Christine A Fischetti; Lynn M Hassman; Nikolaos M Nikolaidis; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-27       Impact factor: 6.914

6.  Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

Authors:  Gerald Willimsky; Thomas Blankenstein
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

7.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

Review 8.  Oncogene addiction: sometimes a temporary slavery.

Authors:  Jos Jonkers; Anton Berns
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

9.  Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.

Authors:  Kathleen Anders; Christian Buschow; Andreas Herrmann; Ana Milojkovic; Christoph Loddenkemper; Thomas Kammertoens; Peter Daniel; Hua Yu; Jehad Charo; Thomas Blankenstein
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

10.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more
  6 in total

1.  Characterization of inducible models of Tay-Sachs and related disease.

Authors:  Timothy J Sargeant; Deborah J Drage; Susan Wang; Apostolos A Apostolakis; Timothy M Cox; M Begoña Cachón-González
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

2.  Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivo.

Authors:  Nicole R Leitner; Caroline Lassnig; Rita Rom; Susanne Heider; Zsuzsanna Bago-Horvath; Robert Eferl; Simone Müller; Thomas Kolbe; Lukas Kenner; Thomas Rülicke; Birgit Strobl; Mathias Müller
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

3.  Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia.

Authors:  Elizabeth Mercado-Ayón; Nathan Warren; Sarah Halawani; Layne N Rodden; Lucie Ngaba; Yi Na Dong; Joshua C Chang; Carlos Fonck; Fulvio Mavilio; David R Lynch; Hong Lin
Journal:  Front Neurosci       Date:  2022-03-24       Impact factor: 4.677

4.  A controlled double-duration inducible gene expression system for cartilage tissue engineering.

Authors:  Ying Ma; Junxiang Li; Yi Yao; Daixu Wei; Rui Wang; Qiong Wu
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

Review 5.  Tet-On Systems For Doxycycline-inducible Gene Expression.

Authors:  Atze T Das; Liliane Tenenbaum; Ben Berkhout
Journal:  Curr Gene Ther       Date:  2016       Impact factor: 4.391

6.  Preventing tumor escape by targeting a post-proteasomal trimming independent epitope.

Authors:  Ana Textor; Karin Schmidt; Peter-M Kloetzel; Bianca Weißbrich; Cynthia Perez; Jehad Charo; Kathleen Anders; John Sidney; Alessandro Sette; Ton N M Schumacher; Christin Keller; Dirk H Busch; Ulrike Seifert; Thomas Blankenstein
Journal:  J Exp Med       Date:  2016-10-03       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.